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Dear Editor,
Infection due to Plasmodium falciparum is a serious public
health threat in sub-Saharan Africa. Malaria endemic foci
are often times affected by other infectious agents which
may contribute to the clinical episodes of the disease.1 Hep-
atitis B virus is one of such infectious agents that coexist
with P. falciparum in most endemic areas. Although the accu-
rate infection status due to hepatitis B virus infection is not
yet known, an estimated 350 million persons worldwide are
chronic carriers.2,3 Since both infectious agents make use
of host liver cells for intracellular multiplication, parasites
induced direct or immunologically mediated interactions in
concurrent infections could potentially escalate or inhibit
progression of both infections.4 While there are several epi-
demiological studies on malaria parasites and hepatitis B virus
single infection in Nigeria and other parts of sub-Saharan
Africa, very few focused on concomitant occurrence of these
two pathogens. There is a need to gather more  epidemiological
data on their concurrent existence to determine the possi-
ble associations between these infectious agents. Thus, this
study determined the coexistence of P. falciparum and hepati-
tis B virus among regular attendees of Queen’s Clinic, a private
hospital located in Abuja, Nigeria.
The cross-sectional study was conducted from May to
August 2014 in individuals aged 4–73 years. The subjects
Table 1 – Associations between malaria parasites and hepatitis
Variables Groups No.
examined
Malaria positiv
(HBsAg+) 
Age (years) 4–12 3 3(0) 
13–21 38 22(5) 
22–30 49 10(1) 
31–39 43 16(3) 
≥40 33 4(2) 
Sex Male 66 19(4) 
Female 100 36(7) 
Total 166 55(11) lation
included those who visited the hospital for medical consul-
tation. Blood sample collected by venipuncture was smeared
into thin and thick ﬁlms, air dried and stained with ﬁeld’s
stain A and B and then examined for presence of malaria
parasites. Hepatitis B virus was diagnosed using rapid sero-
logical kit according to manufacturer’s instructions. The study
was approved by the Babcock University Ethical Review Com-
mittee, Ogun State, Nigeria. The analysis of the data was
performed by GraphPad Prism, version 5. The differences in
proportion of single and co-infection status were tested by
Chi-square test. Multivariate logistic regression analysis was
used to determine the extent of the association between age,
sex, and disease occurrence.
A total of 166 subjects were recruited in the study. Only
P. falciparum was diagnosed in the subjects. The prevalence
of P. falciparum,  hepatitis B virus, and co-infection of the two
pathogens was 33.1%, 22.9%, and 6.6% respectively. While the
prevalence of malaria was age dependent (p < 0.0001), hepati-
tis B virus infection and co-infection of the two pathogens
was  neither age nor sex dependent (p > 0.05) (Table 1). The
prevalence of hepatitis B virus in P. falciparum infected and
non-infected individuals was 20.0% and 24.3% respectively.
This study shows the persistence of malaria and hepatitis B virus.
e Malaria negative p-value
Prevalence
HBsAg
(HBsAg+) Prevalence
(HBsAg+)
0.0 0(0) 0.0 0.317
22.7 16(9) 56.3
10.0 39(10) 25.6
18.8 27(4) 14.8
50.0 29(4) 13.8
21.1 47(10) 21.3 0.969
19.4 64(17) 26.6
20.0 111(27) 24.3
B virus in Nigerian urban centres. More rational methods
towards the control of these diseases are advocated. While
integrated control measures targeted at various stages are
 2 0 1 
s
p
p
t
i
F
N
C
O
m
t
m
C
T
r
1
2
3
4b r a z j i n f e c t d i s .
uggested for malaria, wider hepatitis B virus vaccination
rogramme coverage is warranted. Co-infection of the two
athogens suggests a negative interaction but more  prospec-
ive studies with larger sample size and consideration of
mmune interplay is recommended.
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